Share: Facebook Twitter LinkedIn
Activity Provided By:


COVID-19 and Rheumatology Care: How Does it Impact My Patients?

Access Activity

Overview / Abstract:

Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field that provide the dimension and context needed to interpret the latest data and guidance.

This CME-certified session tackles the tough questions surrounding COVID-19 and rheumatology care with discussion on:
• Impact of immunomodulatory therapies on COVID-19 infection risk
• Vaccine considerations
• Telemedicine
• Long-hauler symptoms post-acute COVID-19 illness

CME/CPE credit available!


Apr 06, 2022


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Respiratory Therapy CE


Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY

Jonathan Jones, MD
Samaritan Rheumatology
Corvallis, OR

Activity Specialities / Related Topics

Family Medicine, Immunizations / Vaccinations, Immunology / Immunosuppression, Internal Medicine, Primary Care, Rheumatology / Arthritis, Telemedicine / Telepharmacy

Sponsors / Supporters / Grant Providers

Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Cardinal Health.

Keywords / Search Terms

ACHL Cardinal Health,COVID-19, Rheumatoid Arthritis, RA, RA Guidelines, inflammation, rheumatologist, internist, pain management, inflammatory disease, autoimmune disorders, immune-mediated inflammatory diseases, cytokine-mediated inflammatory diseases, chronic inflammation, novel rheumatology drugs, tofacitinib, baricitinib, filgotinib, upadacitinib, Immunomodulatory treatment, ACR guidelines, IIL-6 inhibitors, telemedicine Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map